Biocompatibility blood compatibility

Newly developed injectable CNTs will require both in vitro and in vivo testing to determine biocompatibility, blood compatibility, mechanical stability, and safety (Pearce et al., 2007). Here, we review the current articles on toxicity of CNTs and in vivo barriers. 

CNTs are of importance as useful bio-nanomaterials for pharmaceutical applications and biomedical engineering. However, despite the contribution of CNTs to bio-nanomaterials for pharmaceutical applications, the potential risks of CNTs about the exposure to human health have not been adequately assessed. Toxicology issues associated with CNT inhalation, dermal toxicity, pulmonary, biodistribution, biocompatibility, blood compatibility, and elimination need to be addressed prior to their pharmacological application in humans. 

The design of biocompatible (blood compatible) potentiometric ion sensors was described in this chapter. Sensing membranes fabricated by crosslinked poly(dimethylsiloxane) (silicone rubber) and sol-gel-derived materials are excellent for potentiometric ion sensors. Their sensor membrane properties are comparable to conventional plasticized-PVC membranes, and their thrombogenic properties are superior to the PVC-based membranes. Specifically, membranes modified chemically by neutral carriers and anion excluders are very promising, because the toxicity is alleviated drastically. The sensor properties are still excellent in spite of the chemical bonding of neutral carriers on membranes. 

As shown in Fig. 3, there are many aspects of interfacial biocompatibility. In this subsection typical interfacial biocompatibility, blood compatibility, and tissue connectivity will be explained. 

Blood compatibility see Biocompatibility Born-Oppenheimer separation 180, 182 Branch points, labeled 164 Branches, in star polymers 162... 

Coatings for hip j oints, heart valves, and other prostheses DLC is biocompatible and blood compatible,... 

Similarly to the phospholipid polymers, the MPC polymers show excellent biocompatibility and blood compatibility [43—48]. These properties are based on the bioinert character of the MPC polymers, i.e., inhibition of specific interaction with biomolecules [49, 50]. Recently, the MPC polymers have been applied to various medical and pharmaceutical applications [44-47, 51-55]. The crosslinked MPC polymers provide good hydrogels and they have been used in the manufacture of soft contact lenses. We have applied the MPC polymer hydrogel as a cell-encapsulation matrix due to its excellent cytocompatibility. At the same time, to prepare a spontaneously forming reversible hydrogel, we focused on the reversible covalent bonding formed between phenylboronic acid and polyol in an aqueous system. 

Polyelectrolytes have been widely investigated as components of biocompatible materials. Biomaterials come into contact with blood when used as components in invasive instruments, implant devices, extracorporeal devices in contact with blood flow, implanted parts of hard structural elements, implanted parts of organs, implanted soft tissue substitutes and drug delivery devices. Approaches to the development of blood compatible materials include surface modification to give blood compatibility, polyelectrolyte-based systems which adsorb and/or release heparin as well as polyelectrolytes which mimic the biological activity of heparin. 

Biocompatibility (See Table 1), which is a phenomenological concept, is the essential property of biomaterials. For instance, the inner surface of an implanted vascular graft or blood pump (artificial heart) must be blood-compatible, while its outer surface must be tissue-compatible. In other words, the material surfaces must not exert any adverse elfects upon blood or tissue, or upon other biological elements at the interfaces. 

The conclusion drawn from the above-discussed features of native endothelium is that—where feasible—construction of host endothelium on the surface of synthetic implants—i.e. engineered endothelialization—may present a promising pathway for fundamentally resolving the biocompatibility and bio-functionality of artificial cardiovascular transplantation. This proposed biocompatibility is, however, not simply thromboresistance (or blood compatibility) plus blood-cell compatibility, but a real bioactive, self-renewable and specifically functional alliance of tissues and synthetics. 

The long quest for blood-compatible materials to some extent overshadows the vast number of other applications of polymers in medicine. Development and testing of biocompatible materials have in fact been pursued by a significant number of chemical engineers in collaboration with physicians, with incremental but no revolutionary results to date. Progress is certainly evident, however the Jarvik-7 artificial heart is largely built from polymers [34]. Much attention has been focused on new classes of materials, such... 

When a similar plasma polymerization coating was applied on the surface of a memory-expandable stainless steel stent, whose bare surface has notoriously poor blood compatibility, and implanted in a pig without using any drug to suppress blood coagulation, all five coated samples stayed patent, whereas uncoated stents with drug showed partial to total closure [7]. Such a clear-cut result, i.e., 5 out of 5 patency, has been scarcely seen in any animal experiments, which again seems to indicate the superior biocompatibility of imperturbable surfaces created with LCVD coatings. 

In recent years the surface characterization of biomaterials has been forcefully emphasized (1—3). Unfortunately, a clear understanding of how surface characterization can be of value to biomaterials research, development, and production has, in many cases, not been realized. This chapter addresses the subject of surface characterization of biomaterials by considering three aspects of the problem first how surfaces differ from the bulk of materials second, how the important parameters of surfaces can be measured and what new techniques might be developed and finally, how surface characterization can help in understanding and predicting the biocompatibility (and in particular, the blood compatibility) of synthetic materials. 

---